HomeTargets › CD20

CD20 (2 companies · 9 programs)

Companies with an active program directed at CD20.

Artiva Biotherapeutics, Inc. ARTV

  • AlloNK — Rheumatoid Arthritis Phase 1
  • AlloNK — Sjögren's Disease Phase 2
  • AlloNK — Systemic Sclerosis Phase 2
  • AlloNK — Idiopathic Inflammatory Myopathies Phase 2
  • AlloNK — Systemic Lupus Erythematosus Phase 1
  • AlloNK — Lupus Nephritis Phase 1
  • AlloNK — Pemphigus Vulgaris Phase 1
  • AlloNK — ANCA-Associated Vasculitis Phase 1